News
USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- USA News Group News Commentary - The oncology landscape is being pulled ...
From the June 1978 issue of Car and Driver. Auto lore is full of brilliant innovations born too soon. Chevy's 1917 V-8, ...
Subcutaneous isatuximab administered via an on-body injector appears to be as safe and effective as intravenous isatuximab in patients with relapsed or refractory multiple myeloma.
A recent webinar from BD shared important insights into patient fear and anxiety over self-injection and how the right device ...
Vietnam veteran Richard Gerald Jordan is set to be executed in Mississippi nearly 50 years after being sentenced to death. Jordan is scheduled to be executed Wednesday for murdering a ...
Trial Supports Subcutaneous Isatuximab as Effective Alternative to IV Version: Xavier Leleu, MD, PhD
The phase 3 IRAKLIA trial found that subcutaneous isatuximab delivered via an on-body system was as effective and safe as intravenous (IV) administration in relapsed/refractory multiple myeloma, ...
For glabellar lines: 4 units (0.1 milliliters [mL]) injected into each of the five sites for a total dose of 20 units.; For muscles under the eyelids: 4 units/0.1 mL administered into three sites per ...
Metaplanet Supercharges Bitcoin Strategy With $5 Billion US Capital Injection . The company announced that its board of directors approved an additional capital contribution of up to $5 billion to ...
Mequindox (MEQ) is a quinoxaline-N,N-dioxide antibiotic used in food-producing animals. MEQ residue in animal-derived foods is a food safety concern. The tissue distribution of MEQ and its marker ...
Objective To compare the relative bioavailability, safety and tolerability of oral methotrexate (MTX) and subcutaneous (SC) MTX administered via an auto-injector (MTXAI) in patients with rheumatoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results